Literature DB >> 9008101

Expression of androgen receptors in astrocytoma.

Y G Chung1, H K Kim, H K Lee, K C Lee.   

Abstract

Thirty-two cases of surgically removed astrocytoma were evaluated for the expression of androgen receptors(ARs) immunohistochemically and the relationships between androgen receptors, DNA ploidy pattern, and survival of patients were studied. The cases included 18 grade I/II astrocytomas, 4 anaplastic astrocytomas, and 10 glioblastoma multiforme(GBM). Positive AR was present in 12 out of 32 cases(38%), which consisted of 5 cases in grade I/II(28%), 3 cases in anaplastic astrocytoma(75%), and 4 cases in GBM(40%). For both low and high grade astrocytomas, sex and ploidy pattern were not correlated with expression of the androgen receptors. Androgen receptor expression did not significantly affect the survival time. This study confirms previous reports of a low incidence of androgen receptors in astrocytomas. In addition, it shows that expression of androgen receptors is not correlated with DNA ploidy pattern and survival of patients in astrocytoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9008101      PMCID: PMC3054254          DOI: 10.3346/jkms.1996.11.6.517

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  6 in total

1.  Evidence for involvement of steroid receptors and coactivators in neuroepithelial and meningothelial tumors.

Authors:  Mengying Liu; Kaiyuan Zhang; Yangang Zhao; Qiang Guo; Deyu Guo; Jiqiang Zhang
Journal:  Tumour Biol       Date:  2014-12-23

2.  Pharmacokinetic and brain distribution study of an anti-glioblastoma agent in mice by HPLC-MS/MS.

Authors:  Yaxin Li; Raina Dano; Cathy Li; Wenjing Zhang; Justin D Lathia; Bingcheng Wang; Bin Su
Journal:  Biomed Chromatogr       Date:  2022-01-12       Impact factor: 1.911

3.  Expression of the Androgen Receptor Governs Radiation Resistance in a Subset of Glioblastomas Vulnerable to Antiandrogen Therapy.

Authors:  Christian K Werner; Uchechi J Nna; Hanshi Sun; Kari Wilder-Romans; Joseph Dresser; Ayesha U Kothari; Weihua Zhou; Yangyang Yao; Arvind Rao; Stefanie Stallard; Carl Koschmann; Tarik Bor; Waldemar Debinski; Alexander M Hegedus; Meredith A Morgan; Sriram Venneti; Edwina Baskin-Bey; Daniel E Spratt; Howard Colman; Jann N Sarkaria; Arul M Chinnaiyan; Joel R Eisner; Corey Speers; Theodore S Lawrence; Roy E Strowd; Daniel R Wahl
Journal:  Mol Cancer Ther       Date:  2020-08-12       Impact factor: 6.261

Review 4.  Impact of sex in the prevalence and progression of glioblastomas: the role of gonadal steroid hormones.

Authors:  Claudia Bello-Alvarez; Ignacio Camacho-Arroyo
Journal:  Biol Sex Differ       Date:  2021-03-22       Impact factor: 5.027

Review 5.  Astrocytoma: A Hormone-Sensitive Tumor?

Authors:  Alex Hirtz; Fabien Rech; Hélène Dubois-Pot-Schneider; Hélène Dumond
Journal:  Int J Mol Sci       Date:  2020-11-30       Impact factor: 5.923

6.  Androgen Receptor, Although Not a Specific Marker For, Is a Novel Target to Suppress Glioma Stem Cells as a Therapeutic Strategy for Glioblastoma.

Authors:  Nan Zhao; Fei Wang; Shaheen Ahmed; Kan Liu; Chi Zhang; Sahara J Cathcart; Dominick J DiMaio; Michael Punsoni; Bingjie Guan; Ping Zhou; Shuo Wang; Surinder K Batra; Tatiana Bronich; Tom K Hei; Chi Lin; Chi Zhang
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.